Home » Topics » BioWorld Science

BioWorld Science
RSS

NeoTherapeutics' cognition enhancer in preclinical testing

Dec. 4, 1997

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Dec. 4, 1997

Results of IDEC-151/SB-217969 phase I trial reported

Dec. 4, 1997

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

New glucocorticoid from Kissei under development for asthma

Dec. 4, 1997

New inhibitor of inflammatory bone resorption presented at Tokyo congress

Dec. 4, 1997

Method of inactivating RNA viruses offered for licensing

Dec. 4, 1997

Actinomycin D: new use in AIDS therapy available for licensing

Dec. 4, 1997

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

Bayer develops CETP inhibitors

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...